Should You Test for Thalassemia and Refer to Hematology?
Yes, you should test for thalassemia when you find microcytosis with normal or low-normal iron studies, particularly in patients from high-risk ethnic backgrounds (Mediterranean, Middle Eastern, African, or Southeast Asian descent), and refer to hematology if confirmed positive or if anemia persists despite adequate iron replacement.
When to Suspect Thalassemia
The key clinical scenario requiring thalassemia testing is microcytosis (MCV < 80 fL) and/or hypochromia (MCH < 27 pg) in the presence of normal iron studies 1. This is the critical pitfall—thalassemia is frequently misdiagnosed as treatment-resistant iron deficiency anemia 2.
Specific Red Flags:
- MCV disproportionately low for the degree of anemia (typically MCV 60-70 fL in β-thalassemia carriers) 1
- Normal or elevated red blood cell count despite microcytosis 3
- Elevated red cell distribution width (RDW) suggesting combined deficiency 3
- Failure to respond to adequate iron replacement after excluding ongoing blood loss 2
- Ferritin normal but microcytosis persists 1
Diagnostic Algorithm
Step 1: Initial Screening
Order simultaneously:
- Complete blood count with indices (MCV, MCH, RBC count)
- Serum ferritin (to exclude iron deficiency)
- Iron studies if ferritin is equivocal (15-45 μg/L range) 1
Step 2: If Microcytosis + Normal Iron Studies
Proceed immediately to:
- Hemoglobin electrophoresis or HPLC with HbA2 and HbF quantitation 4, 5
- Brilliant cresyl blue stained blood smear (H body staining) to detect α-thalassemia 4
The British Society of Gastroenterology specifically recommends Hb electrophoresis in those with microcytosis and normal iron studies, particularly with appropriate ethnic background 1.
Step 3: Interpretation
- β-thalassemia trait: Elevated HbA2 (>3.5%), MCV 60-70 fL, MCH 19-23 pg 5
- α-thalassemia trait: Normal or low HbA2, H bodies present on special staining, milder microcytosis 1, 5
- Normal electrophoresis but persistent microcytosis: Consider α-thalassemia (requires molecular testing for confirmation) 5
When to Refer to Hematology
Mandatory Referral Situations:
- Confirmed thalassemia carrier with reproductive implications - requires genetic counseling for partner testing and prenatal diagnosis options 4
- Anemia inadequate response to iron despite correction of deficiency - to evaluate for additional or alternative causes 6
- Suspected thalassemia major or intermedia - any patient requiring transfusions or with severe anemia 7
- Abnormalities in two or more cell lines (WBC, Hb, platelets) - suggests bone marrow dysfunction requiring hematology evaluation 8
Consider Referral:
- Patients with confirmed thalassemia trait planning pregnancy (for partner screening and genetic counseling) 4
- Complex cases where molecular diagnosis is needed to clarify carrier status 4, 5
Critical Pitfalls to Avoid
Do not assume iron deficiency based solely on microcytosis. The specificity of MCV and MCH for iron deficiency is limited, as microcytosis occurs in thalassemia, where MCV is typically reduced out of proportion to anemia 1.
Do not give prolonged empiric iron therapy without confirming iron deficiency. This leads to unnecessary treatment and delayed diagnosis 2. If ferritin is normal (>30 μg/L) and there's no evidence of inflammation, proceed directly to hemoglobin analysis 1.
Remember ferritin is an acute phase protein. Apparently normal ferritin levels may mask iron deficiency in inflammatory states. In this scenario, check transferrin saturation and consider a trial of iron if clinical suspicion is high 1.
Do not miss combined deficiency. Thalassemia carriers can also have iron deficiency. An elevated RDW suggests this possibility 3. Treat the iron deficiency first, then reassess—persistent microcytosis after iron repletion confirms thalassemia 1.
Ethnic Background Considerations
While thalassemia screening should be offered to high-risk ethnic populations (Mediterranean, Middle Eastern, African, Southeast Asian) 4, do not exclude testing based solely on ethnicity if the laboratory picture is suggestive. Thalassemia can present in any population, and the diagnosis may be missed in patients without classic ethnic backgrounds 2.